These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 22569105)
1. Mucinous adenocarcinoma of the endometrium: case series and review of the literature. Jalloul RJ; Elshaikh MA; Ali-Fehmi R; Haley MM; Yoon J; Mahan M; Munkarah AR Int J Gynecol Cancer; 2012 Jun; 22(5):812-8. PubMed ID: 22569105 [TBL] [Abstract][Full Text] [Related]
2. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy? Velker V; D'Souza D; Prefontaine M; McGee J; Leung E Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823 [TBL] [Abstract][Full Text] [Related]
3. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma. Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study. Kuku S; Williams M; McCormack M Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205 [TBL] [Abstract][Full Text] [Related]
5. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850 [TBL] [Abstract][Full Text] [Related]
7. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK; Zhang HT; Sun YC; Wu LY Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912 [TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence]. Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194 [TBL] [Abstract][Full Text] [Related]
9. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases. Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230 [TBL] [Abstract][Full Text] [Related]
10. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [TBL] [Abstract][Full Text] [Related]
11. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Feng W; Hua K; Malpica A; Zhou X; Baak JP Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438 [TBL] [Abstract][Full Text] [Related]
12. Survival outcomes and patterns of failure in women with stage IIIC Lee JK; Mahan M; Hanna RK; Elshaikh MA Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504 [TBL] [Abstract][Full Text] [Related]
13. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran. Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014 [TBL] [Abstract][Full Text] [Related]
14. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review. Growdon WB; Rauh-Hain JJ; Cordon A; Garrett L; Schorge JO; Goodman A; Boruta DM; Horowitz NS; del Carmen MG Int J Gynecol Cancer; 2012 Mar; 22(3):417-24. PubMed ID: 22237383 [TBL] [Abstract][Full Text] [Related]
15. Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study. Bao L; Ding Y; Cai Q; Ning Y; Hu W; Xue X; Sun H; Hua K; Zhou X; Yi X Int J Gynecol Cancer; 2016 Mar; 26(3):424-30. PubMed ID: 26825825 [TBL] [Abstract][Full Text] [Related]
16. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. Klopp AH; Jhingran A; Ramondetta L; Lu K; Gershenson DM; Eifel PJ Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709 [TBL] [Abstract][Full Text] [Related]
17. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients. Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455 [TBL] [Abstract][Full Text] [Related]
18. Treatment results of endometrial carcinoma with positive peritoneal washing, adnexal involvement and serosal involvement. Wong FC; Pang CP; Tang SK; Tung SY; Leung TW; Sze WK; Cheung KB Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):350-5. PubMed ID: 15341439 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of adjuvant chemotherapy and vaginal brachytherapy with or without pelvic radiation for surgical stage I-II uterine serous carcinoma. Robbins JR; Siddiqui MS; Al-Wahab Z; Laser B; Lu M; Ali-Fehmi R; Munkarah A; Elshaikh MA Eur J Gynaecol Oncol; 2012; 33(5):449-54. PubMed ID: 23185785 [TBL] [Abstract][Full Text] [Related]
20. Small cell neuroendocrine carcinoma of the endometrium: a clinicopathologic study of six cases. Koo YJ; Kim DY; Kim KR; Kim JH; Kim YM; Kim YT; Nam JH Taiwan J Obstet Gynecol; 2014 Sep; 53(3):355-9. PubMed ID: 25286790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]